NCT01540760View on ClinicalTrials.gov

A Study of MCAF5352A in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Healthy Volunteer

Interventions

DRUG

MCAF5352A

Multiple ascending doses

DRUG

Placebo

Matching MCAF5352A, multiple doses

Trial Locations (1)

G1P 0A2

Québec

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY